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Introduction: Concomitance of chron-
ic periodontitis (CP) in patients with 
chronic kidney disease (CKD) have 
been associated with adverse outcomes. 
Vitamin D (25(OH)D) deficiency my 
play a role in CP and inadequate vita-
min D status is common among patients 
with CKD. Objective: To examine the 
relationship between vitamin 25(OH)
D and CP in patients with CKD not 
yet on dialysis. Methods: A case-con-
trol study was conducted. Cases and 
controls were defined as patients with 
CKD with and without CP, respective-
ly. The demographic, clinical and lab-
oratory data were obtained when the 
patient was attended in the outpatient 
clinic. CKD was defined and staged ac-
cording to the NKF QDOKITM. Serum 
25(OH)D levels were measured by che-
miluminescence when assessing the CP, 
which was definined according to the 
American Academy of Periodontoly 
(1999). Serum 25(OH)D levels were 
stratified into deficient (≤ 14 ƞg/mL), 
insufficient (15-29 ƞg/mL) and suffi-
ciency (≥ 30 ƞg/mL). Results: A total of 
15 cases were compared with 14 con-
trols. Cases had lower median 25(OH)
D levels than controls (22.6 versus 
28.6 ƞg/mL, p < 0.01) and were more 
likely to be categorized as vitamin D 
insufficiency/deficiency (93,3% ver-
sus 57,1%, p < 0,004). On the other 
hand, the percentage of controls with 
vitamin D sufficiency was higher then 
cases (42,9% versus 6,7%, p < 0,004). 
Conclusion: In patients with CKD not 
yet on dialysis, vitamin D deficiency is 
associated with CP.
Serum levels of vitamin D and chronic periodontitis in 
patients with chronic kidney disease
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IntroductIon
Chronic periodontitis (CP) is a subgin-
gival infection predominantly caused 
by gram-negative1 bacteria and is char-
acterized by periods of exacerbation 
and remission. In Brazil, about 70% of 
persons over the age of 30 years have 
moderate CP, represented by a clini-
cal attachment level (CAL) of ≥ 5 mm, 
and 52% have the severe form of the 
disease (CAL ≥ 7 mm).2 Patients un-
dergoing predialysis and hemodialysis 
showed a prevalence of more severe CP 
when compared with peritoneal dialy-
sis patients and healthy persons.3 CP in 
its severe form can lead to dental loss4 
and is associated with increased risks 
of cardiovascular disease,5 inadequate 
glycemic control in patients with type 
2 diabetes mellitus,6 complicated preg-
nancy,7 and stroke,8 and is considered a 
major public health problem that can be 
prevented and treated.
Recent studies suggest a high preva-
lence of CP in patients with chronic 
kidney disease (CKD), both in the pre-
dialytic9,10 and dialytic stages.11,12 In 
patients with CKD, CP is more serious 
and there is a higher prevalence of peri-
odontal bacterial pathogens compared 
with healthy persons.13 The unfavor-
able impact of the occurrence of CP in 
the course of CKD is not fully defined; 
however, its unfavorable association 
with cardiovascular diseases,14 a leading 
cause of death in patients with kidney 
disease,15 may constitute a new, as of yet 
undervalued risk factor.
DOI: 10.5935/01012800.20130004
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Vitamin D plays an important role in the immune 
response and may play a key role in CP observed 
in patients with CKD. Studies have reported an 
association between periodontal health and intake of 
vitamin D.16,17 Vitamin D and calcium supplements 
improve periodontal health, increase bone density in 
the jaw bone, and inhibit alveolar bone resorption.18,19 
We postulate that an inadequate level of vitamin D 
promotes the occurrence of CP in patients with CKD; 
therefore, the objective of this study was to examine 
the relation between serum vitamin D levels and CP 
in patients with predialysis CKD.
Methods
This was a case-control study of patients treated 
at the secondary prevention outpatient unit of 
the Nucleus of Interdisciplinary Studies, Research 
and Treatment of Nephrology (NIEPEN), Federal 
University of Juiz de Fora and IMEPEN Foundation, 
from 11/2009 to 08/2012.
Patients of both sexes and with predialysis CKD 
stages 3B to 5, in the 30-78 years age group, were 
included. Patients who were smokers, those using 
anti-inflammatory drugs, those using antibiot-
ics in the last 3 months, pregnant women, cancer 
patients, HIV patients, uncompensated diabetics, 
patients with other infections or fever of undeter-
mined origin, those treated for periodontitis in the 
last 6 months, and those with aggressive or acute 
periodontal disease were excluded.
The glomerular filtration rate (GFR) was esti-
mated on the basis of the concentration of serum 
creatinine, using the equation developed by the 
CKD-EPI (Chronic Kidney Disease Epidemiology 
Collaboration) study group.20 The diagnosis of 
CKD followed the criteria proposed by the NKF 
KDOQITM (National Kidney Foundation/Kidney 
Disease Outcomes Quality Initiative).21
The level of 25-hydroxyvitamin D, 25(OH)D, 
was assessed by a chemiluminescence analysis of 
serum stored at -80°C, obtained on the day of peri-
odontal examination. The serum levels of 25(OH)
D were used as organic reserves of vitamin D. 
The serum 25(OH)D level is the combination of 
endogenous and exogenous sources of vitamin D 
and presents prolonged half-life.22 25(OH)D levels 
were stratified into deficiency (≤ 14 ƞg/mL), insuffi-
ciency (15-29 ƞg/mL), and sufficiency (≥ 30 ƞg/mL).
Periodontal examination was conducted by 
2 suitably qualified examiners. All teeth, except 
the third molars, were examined. Probing depth 
(PD) and gingival recession were measured at 6 
sites per tooth (mesio-buccal, buccal, disto-buc-
cal, mesio-lingual, lingual, disto-lingual) by using 
an electronic probe (Florida Probe Corp., USA). 
The measurements were expressed in millimeters. 
The CAL was calculated using the distance of the 
PD from the cementum/enamel junction, added to 
gum recession, and subtracting gingival hyperpla-
sia. The number of sites with plaque was quanti-
fied by the presence or absence of supragingival 
dental plaque as well as the number of sites with 
bleeding on probing.
The professional skill was tested by the correla-
tion coefficient, using the k-test. The intra-exam-
iner coefficient was 0.84 and the inter-examiner 
coefficient was 0.82.
The project was approved by the Ethics in 
Research Committee (CEP-HU/CAS) of the 
Federal University of Juiz de Fora, Opinion 
Nº 0130/2009; cover page: 290100; CAAE: 
0107.0.420.000-09.
StatiSticS
Data were collected and processed using SPSS, 
version 15.0 (Chicago, IL, USA). The results were 
presented as medians and values (minimum and 
maximum) for numeric variables, and absolute and 
relative frequencies for categorical variables. To 
compare the variables between groups, the Mann-
Whitney test for numerical variables and the c2 or 
Fisher exact test (when the expected frequencies 
were < 5) for categorical variables were applied. 
Statistical difference was considered for p values 
< 0.05.
results
Of the 623 patients initially assessed, 594 were 
excluded for the following reasons: a GFR of > 
44 mL/mi/1.73 m2 (252), nonattendance to peri-
odontal evaluation and blood collection (139), total 
edentulism (108), smoking (48), refusal to partici-
pate in the study (31), and no indication of peri-
odontal evaluation (16). Twenty-nine patients met 
the inclusion criteria, 15 in the case group (CKD 
and CP) and 14 in the control group (CKD without 
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CP), with a similar median age in both groups. The 
case group, compared with the control group, was 
composed primarily of male patients and diabet-
ics; however, the differences were not statistically 
significant (Table 1). The most common causes of 
CKD were diabetic renal disease in patients in the 
case group and hypertensive nephropathy and dia-
betic kidney disease in the control group. There was 
a statistical difference in the median systolic blood 
pressure (140 mmHg vs. 130 mmHg, p < 0.05) and 
parathyroid hormone levels (105 pg/mL vs. 53 pg/
mL, p < 0.05), both being higher in case patients 
than in control patients.
As expected, a statistical difference was ob-
served in all clinical periodontal parameters in the 
comparison groups. Case patients had higher local 
inflammation and CP characterized as moderate 
to severe, with involvement of many sites of the 
mouth (PD ≥ 5 mm = 5.5% and CAL ≥ 6 mm = 
32%, p < 0.001). There was no statistical signifi-
cance in the number of teeth (Table 2).
Case patients had a lower median level of 25(OH)
D than control patients (22.6 vs. 28.6 ƞg/mL, 
p < 0.01) (Figure 1). The percentage of CKD pa-
tients with and without CP in accordance with the 
levels of 25(OH)D was 33.3% vs. 0% in the de-
ficiency group, 60% vs. 57.1% in the insufficien-
cy group, and 6.7% vs. 42.9% in the sufficiency 
group (p < 0.004). The percentage of patients with 
insufficiency or deficiency of 25(OH)D was sig-
nificantly greater among case patients than among 
control patients (93.3% vs. 57.1%, p < 0.004).
dIscussIon
This study shows that patients with CKD and 
CP have lower serum levels of vitamin D and are 
most often insufficient and deficient in 25(OH)
D in relation to CKD patients without CP. This 
association was evident despite excluding several 
confounding factors such as smoking, use of 
anti-inflammatory medications, recent antibiotic 
use, pregnancy, cancer, infection with human 
Variables
CKD with CP (n =15), 
median (min-max)
CKD without CP (n = 14), 
median (min-max)
p-value
Age, years 63 (51-72) 64 (30-78) 0.5
Sex (male), % 67 50 0.2
Diabetes, % 46 21 0.1
Hypertension, % 86 93 0.5
Basal disease 0.5
Hypertensive nephropathy, % 20 21.4
Diabetic nephropathy, % 40 21.5
Chronic glomerulonephritis, % 6.7 14.3
Other and unspecified, % 33.3 42.8
Systolic blood pressure, (mmHg) 140 (100-190) 130 (100-180) 0.014
Diastolic blood pressure, (mmHg) 80 (60-100) 80 (68-130) 0.6
Body mass index, (kg/m2) 27 (17-39) 26 (21-86) 0.8
Serum creatinine, (mg/dL) 1.8 (1.3-5) 1.7 (0.8-3.2) 0.2
GFR, mL/min/1.73 m2 31 (9-63) 32 (15-78) 0.3
Total cholesterol, (mg/dL) 183 (109-330) 192 (119-255) 0.4
Parathyroid hormone, (pg/mL) 105 (39-595) 53 (22-175) 0.02
Distribution of patients according to 25(OH)D levels, n (%) 0.004
≤ 14 ng/mL 5 (33.3) 0
15-29 ng/mL 9 (60) 8 (57.1)
≥ 30 ng/mL 1 (6.7) 6 (42.9)
GFR: Glomerular filtration rate; 25(OH)D, 25-hydroxy vitamin D.
tAble 1 DemOgraphic, clinical, anD labOratOry Data Of chrOnic kiDney DiSeaSe (ckD) patientS with anD withOut  
 chrOnic periODOntitiS (cp)
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immunodeficiency virus, uncompensated diabetes, 
fever of unknown origin or other infections, 
periodontal treatment within the last 6 months, and 
cases of aggressive or acute periodontal disease. The 
results suggest that a sufficient level of vitamin D is 
important in maintaining a healthy periodontium 
and reducing the consequences of CP.
Vitamin D deficiency is not uncommon in Brazil. 
Among the 73 resident physicians of a public hos-
pital in the city of Porto Alegre, with a mean age 
of 26 years, the serum level of 25(OH)D found was 
17.9 ± 8.0 ng/mL, and in 57.4% of them, vitamin 
D levels were < 20 ng/mL.23 In CKD, insufficient 
levels of 25(OH)D, defined as < 30 ng/mL, were 
observed in 39.6% of patients undergoing conser-
vative treatment in São Paulo.24 However, if we 
consider 25(OH)D levels ≥ 40 ng/mL25,26 as suffi-
cient, the percentage of insufficient patients reaches 
51%.27 In this study, 75.8% of CKD patients evalu-
ated had insufficient or deficient levels of vitamin 
D and, of these, 63.6% had CP.
CP is a chronic infectious disease caused by 
gram-negative bacteria, which induces a systemic 
inflammatory response.4 The destruction of local 
periodontal tissue promotes systemic dissemination 
of periodontal pathogens and their products (e.g., 
lipopolysaccharides) and of inflammatory media-
tors (e.g., tumor necrosis factor, interleukin-6) pro-
duced locally.28 In previous studies, CP tended to 
be more severe in patients with CKD undergoing 
dialysis or conservative treatment, compared with 
patients with CP and without systemic diseases.13,29 
In this study, the CP was very well defined in case 
patients, with all clinical parameters used for char-
acterizing periodontal disease being statistically 
different from control patients.
In NHANES III (third National Health and 
Nutritional Examination Survey), a significant 
survey of the adult population of the United 
States of America, insufficient levels of 25(OH)
D were associated independently with CP.16 In a 
randomized trial, the administration of vitamin D 
(700 IU/day) and calcium (500 mg/day) significantly 
reduced tooth loss in older patients during 3 years of 
observation.30 In addition, dietary supplementation 
with vitamin D and calcium improved periodontal 
health, increased jaw bone density, inhibited bone 
resorption,18,19 and decreased the severity of CP.31
tAble 2 evaluatiOn Of clinical periODOntal parameterS in chrOnic kiDney DiSeaSe (ckD) patientS with anD  
 withOut chrOnic periODOntitiS (cp)
Variables
CKD with CP (n =15), 
median (min-max)
CKD without CP (n = 14), 
median (min-max)
p-value
Probing depth, mm 2.1 (1.4-3.7) 1.4 (1.3-1.8) < 0.001
Probing depth ≥ 5 mm, % 5.5 (2-36) *
Clinical attachment level, (mm) 4.5 (1.7-6) 2.2 (1.4-4.9) < 0.001
Clinical attachment level ≥ 6 mm, % 32 (2.7-54) *
Sites with dental plaque, % 85 (2-100) 3.5 < 0.001
Sites with bleeding on probing, % 52 (2-98) *
No. of teeth 14 (4-23) 12 (6-26) 0.9
* Unique and defining factors of the case group for the clinical confirmation of CP; not observed in the control group.
Figure 1. Box-plot representing the median (horizontal line), 
interquartile range (upper and lower), and upper and lower limits 
(rods) of 25(OH)D levels in patients with chronic kidney disease 
(CKD) and chronic periodontitis (CP) (case patients) compared 
with those with CKD without CP (control patients). Case patients 
had a lower median serum level of 25(OH)D than control patients 
(p < 0.01).
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Vitamin D has important functions in immune 
and inflammatory responses and, when lacking, is 
associated with a higher prevalence of infection.32 
Vitamin D acts as an anti-inflammatory agent by 
inhibiting the expression of inflammatory cytokines 
and stimulating monocytes/macrophages to secrete 
molecules with potent antibiotic effects.16,17 Vitamin 
D directly induces the expression of the endogenous 
antimicrobial peptide cathelicidin, the production 
of which is triggered by Toll-like receptors in 
response to bacterial infection. Activation of Toll-
like receptors in human macrophages increases 
the expression of vitamin D receptors and the 
enzyme α-1-hydroxylase. Consequently, there is an 
induction of cathelicidin and an intracellular killing 
of bacteria (e.g., Mycobacterium tuberculosis).33 CP 
is caused by bacteria that stimulate the immune and 
inflammatory responses as part of the organism’s 
defense mechanisms, and responses through Toll-
like receptors are important in the pathogenesis 
of periodontal disease.34,35 Vitamin D appears to 
modulate most of the host’s immune response.36 In 
our study, patients with CKD and CP had lower 
levels of 25(OH)D than control patients without 
CP. We also observed that CP occurred more often 
in patients with < 30 ng/mL 25(OH)D, one-third 
of whom were deficient in vitamin D. Moreover, 
only 6.7% of patients with CKD and CP showed 
sufficient levels of 25(OH)D.
In this study, our concern in the pairing of 
case and control patients as much as possible was 
evident. We matched patients according to several 
traditional confounding factors that are associated 
with CP, such as age, sex, obesity, and smoking. 
However, there was a statistical difference 
between the levels of systolic blood pressure, 
which was higher in patients with CP. Current 
epidemiological evidence reinforces the association 
of CP with high blood pressure. The mechanisms 
involved in this association appear to involve the 
systemic dissemination of periodontal infection, 
host immune response, direct bacterial action on 
the vascular system, endothelial dysfunction37 
and/or hyperparathyroidism,38 and/or inadequate 
regulation of the renin-angiotensin system by 
vitamin D.39
It is known that vitamin D deficiency occurs 
early in the course of CKD40 and is associated with 
secondary hyperparathyroidism.41 These observa-
tions are consistent with our findings of higher lev-
els of intact parathyroid hormone in patients with 
CKD and CP, who are relatively more deficient in 
vitamin D than those with a healthy periodontium.
It is imperative to present some limitations of 
our work. First, the cross-sectional nature of this 
study does not allow us to establish a causative 
association between vitamin D deficiency and 
CP. Second, the strict inclusion and non-inclusion 
criteria limited the sample size. Third, the use of 30 
ng/mL as a cutoff point for establishing the organic 
reserves of 25(OH)D may be debatable since some 
authors recommend levels of 40 ƞg/mL or more as 
optimal.25,26 Finally, it is possible that there are other 
confounding factors that might explain our results.
In summary, our findings suggest that vitamin 
D deficiency predisposes patients with CKD to de-
velop CP, possibly by limiting the patient’s inflam-
matory and immune response against bacterial in-
vasion of the periodontium.
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